NORDEA INVESTMENT MANAGEMENT AB - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 352 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORDEA INVESTMENT MANAGEMENT AB ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$209,362
-56.0%
62,4030.0%0.00%
-100.0%
Q2 2023$475,511
-57.7%
62,403
-44.0%
0.00%
-50.0%
Q1 2023$1,123,006
-17.6%
111,520
-4.2%
0.00%0.0%
Q4 2022$1,363,149
-44.0%
116,409
+2.3%
0.00%
-50.0%
Q3 2022$2,433,000
-29.8%
113,834
-0.5%
0.00%
-20.0%
Q2 2022$3,468,000
-28.0%
114,418
-0.8%
0.01%
-16.7%
Q1 2022$4,820,000
-6.4%
115,319
+1.4%
0.01%0.0%
Q4 2021$5,151,000
-12.1%
113,741
+1.2%
0.01%
-25.0%
Q3 2021$5,860,000
-16.3%
112,374
+1.1%
0.01%
-11.1%
Q2 2021$7,001,000
-25.3%
111,138
+9.3%
0.01%
-35.7%
Q1 2021$9,378,000
+0.9%
101,644
-2.0%
0.01%
-6.7%
Q4 2020$9,291,000
-16.1%
103,692
-2.2%
0.02%
-28.6%
Q3 2020$11,076,000
-31.5%
105,981
-49.6%
0.02%
+23.5%
Q2 2020$16,174,000
+181.0%
210,126
+100.4%
0.02%
+21.4%
Q1 2020$5,755,000
+4.7%
104,875
+4.4%
0.01%
+27.3%
Q4 2019$5,498,000
+52.3%
100,437
+42.4%
0.01%
+37.5%
Q3 2019$3,609,000
+6.6%
70,554
+0.7%
0.01%0.0%
Q2 2019$3,385,000
-53.7%
70,054
-51.6%
0.01%
-46.7%
Q1 2019$7,308,000
-70.9%
144,628
-65.9%
0.02%
-28.6%
Q4 2018$25,134,000
+32.1%
423,960
+46.6%
0.02%
+5.0%
Q3 2018$19,032,000
+135.6%
289,132
+80.7%
0.02%
+5.3%
Q2 2018$8,077,000
+43.6%
159,975
+49.7%
0.02%
+46.2%
Q1 2018$5,626,000
+109.8%
106,861
+85.2%
0.01%
+116.7%
Q4 2017$2,681,000
+10.5%
57,691
-3.9%
0.01%0.0%
Q3 2017$2,427,000
+15.3%
60,006
-3.3%
0.01%
+20.0%
Q2 2017$2,105,000
+48.9%
62,082
+27.5%
0.01%
+25.0%
Q1 2017$1,414,000
+2.4%
48,703
+15.8%
0.00%0.0%
Q4 2016$1,381,000
-0.4%
42,067
-4.3%
0.00%0.0%
Q3 2016$1,386,000
+67.0%
43,966
+48.8%
0.00%
+300.0%
Q2 2016$830,000
+501.4%
29,546
+678.1%
0.00%
Q1 2016$138,000
-17.9%
3,797
-9.6%
0.00%
-100.0%
Q4 2015$168,000
+40.0%
4,2000.0%0.00%
Q3 2015$120,000
-13.0%
4,2000.0%0.00%
Q2 2015$138,0004,2000.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Laurus Investment Counsel Inc. 120,504$10,797,0004.20%
SNYDER CAPITAL MANAGEMENT L P 723,477$64,824,0002.12%
Hillcrest Asset Management LLC 161,428$14,464,0001.97%
RICE HALL JAMES & ASSOCIATES, LLC 587,727$52,660,0001.85%
PALISADE CAPITAL MANAGEMENT, LP 579,009$51,879,0001.33%
Pier Capital, LLC 109,786$9,837,0001.04%
Paradiem, LLC 21,320$2,286,0000.97%
EARNEST PARTNERS LLC 1,390,735$124,610,0000.86%
Ridgewood Investments LLC 10,004$1,034,0000.82%
Tygh Capital Management, Inc. 56,334$5,048,0000.78%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders